|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 52.54 USD | +0.06% |
|
+5.25% | -18.19% |
Company Valuation: Dolby Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,375 | 6,589 | 7,494 | 7,231 | 6,938 | 4,967 | - | - |
| Change | - | -29.72% | 13.74% | -3.51% | -4.05% | -28.41% | - | - |
| Enterprise Value (EV) | 8,103 | 5,772 | 7,494 | 7,231 | 6,938 | 4,967 | 4,967 | 4,967 |
| Change | - | -28.77% | 29.85% | -3.51% | -4.05% | -28.41% | 0% | 0% |
| P/E | 31.1x | 37.3x | 38.2x | 28.2x | 27.6x | 16.2x | 14.4x | - |
| PBR | 3.6x | 2.88x | - | - | 2.65x | 1.86x | - | - |
| PEG | - | -1x | 2.9x | 0.9x | -10.61x | 0.7x | 1.2x | - |
| Capitalization / Revenue | 7.32x | 5.26x | 5.77x | 5.68x | 5.14x | 3.53x | 3.4x | 3.22x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 3.53x | 3.4x | 3.22x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 9.22x | 8.75x | 8.12x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 10.5x | 14.7x | - |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 14.6x | 9.96x | 9.19x |
| FCF Yield | 4.2% | 4.11% | 4.49% | 4.11% | 6.28% | 6.85% | 10% | 10.9% |
| Dividend per Share 2 | 0.91 | 1.02 | 1.11 | - | 1.32 | - | - | - |
| Rate of return | 0.98% | 1.51% | 1.42% | - | 1.82% | - | - | - |
| EPS 2 | 2.97 | 1.81 | 2.05 | 2.69 | 2.62 | 3.25 | 3.653 | - |
| Distribution rate | 30.6% | 56.4% | 54.1% | - | 50.4% | - | - | - |
| Net sales 1 | 1,281 | 1,254 | 1,300 | 1,274 | 1,349 | 1,406 | 1,462 | 1,541 |
| EBITDA 1 | 550.2 | 420.6 | 463.9 | 460.1 | 496.3 | 538.6 | 567.5 | 611.9 |
| EBIT 1 | 344.4 | 206.6 | 215.8 | 258.3 | 265 | 475 | 338.1 | - |
| Net income 1 | 310.2 | 184.1 | 200.7 | 261.8 | 255 | 258.7 | 294.1 | 342.6 |
| Net Debt | -1,272 | -817.6 | - | - | - | - | - | - |
| Reference price 2 | 92.47 | 67.46 | 78.36 | 75.84 | 72.39 | 52.51 | 52.51 | 52.51 |
| Nbr of stocks (in thousands) | 101,387 | 97,677 | 95,641 | 95,348 | 95,844 | 94,598 | - | - |
| Announcement Date | 11/16/21 | 11/17/22 | 11/16/23 | 11/19/24 | 11/18/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 16.16x | - | - | - | 4.97B | ||
| -354.18x | 6.69x | 24.98x | -.--% | 24.52B | ||
| 146.69x | 0.78x | 10.8x | -.--% | 7.07B | ||
| 91x | 1.65x | 11.88x | -.--% | 3.74B | ||
| 20.49x | - | - | - | 411M | ||
| -12.18x | - | - | - | 368M | ||
| Average | -15.34x | 3.04x | 15.89x | 0% | 6.85B | |
| Weighted average by Cap. | -175.83x | 4.97x | 20.76x | 0% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- DLB Stock
- Valuation Dolby Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















